PRN-371

N/A

Report date: 2023/04/23 14:40:27
NME

Base Information

Drug NamePRN-371
Drug Alias NamePRN-371
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionTyrosine-protein kinase JAK3 inhibitors
TargetsTyrosine-protein kinase JAK3
Therapy Area/IndicationsLymphoma, Extranodal NK-T-Cell
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesPrincipia Biopharma Inc
China Registration ClassN/A

Develop Information

Active CompaniesPrincipia Biopharma Inc
Inactive CompaniesN/A
Active IndicationsLymphoma, Extranodal NK-T-Cell
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A